The main goal of Claas's project is to determine the relationship between differentiation potential and immune modulatory function in clonally-selected MSCs of mouse and human.
Mikey's research is in examining the role of modified human endothelial progenitor cells and mesenchynal stem cells in the treatment of cardiovasuclar disease.
Lisa's project is focusing on the generation of tolerogenic bone marrow derived dendritic cells by gene therapy and chemical modification, for the application in allogeneic transplantation.